Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Adenosine and Metformin

supplement:

Adenosine

Research Papers that Mention the Interaction

Metformin inhibits mitochondrial respiratory chain complex I which leads to change in adenosine mono-phosphate ( AMP) to adenosine tri-phosphate (ATP) ratio.
International journal of molecular sciences  •  2021  |  View Paper
This study shows that metformin suppressed CD133 expression mainly by affecting the CD133 P1 promoter via adenosine monophosphate (AMP)-activated protein kinase (AMPK) signaling but not the mammalian target of rapamycin (mTOR).
Neoplasia  •  2019  |  View Paper
Treatment with metformin promoted the phosphorylation of the catalytic &agr; subunit of adenosine 5′‐monophosphate‐activated protein kinase (AMPK&agr;), co‐administration of AMPK inhibitor suppressed the stimulatory effects of metformin on AMPK&agr; phosphorylation.
International immunopharmacology  •  2017  |  View Paper
Our findings showed that activation of AMPK by metformin (300 mg/kg) significantly increased the MNCV and reduced the levels of inflammatory cytokines.
Inflammopharmacology  •  2016  |  View Paper
CONCLUSION Me formin in vivo and ex vivo increases ADO si gnaling in CC, most probably interfering with NO formation and ADO breakdown.
Ex vivo metformin time and dose dependently increased the relaxant effect of ADO in RD.
In vivo metformin treatment in both RD and HFD significantly increased the ADO relaxing effect (P < 0.0001 and P < 0.01, respectively, vs. relative untreated groups) although to a different extent.
The journal of sexual medicine  •  2014  |  View Paper
Experimental studies have shown that metformin can increase the intracellular concentration of adenosine monophosphate , which is a major determinant of the intracellular formation of adenosine.
Journal of cardiovascular pharmacology  •  2009  |  View Paper
However, it is known that metformin stimulates catabolic pathways through the activation of adenosine monophosphate –activated protein kinase (AMPK) [2] and that a synthetic activator of AMPK, 5-aminoimidazole4-carboxamide ribofuranoside (AICAR) inhibits adipogenesis in the pre-adipocyte cell line, 3T3-L1 [3].
Diabetes, obesity & metabolism  •  2008  |  View Paper
Furthermore, metformin treatment for 1 h simultaneously increased the Thr172 phosphorylation of PRKAA ( adenosine 5′ monophosphate-activated protein kinase alpha) and the Ser79 phosphorylation of ACACA (acetyl-Coenzyme A carboxylase alpha).
Biology of reproduction  •  2006  |  View Paper
In addition, metformin significantly increased AMPK activation in CPZ mice.
Metformin , a glucose-lowering drug, attenuates inflammatory responses by activating adenosine monophosphate protein kinase (AMPK) which suppresses nuclear factor kappa B (NF-κB).
Neurotoxicity research  •  2021  |  View Paper
Furthermore, metformin induced adenosine 5′‐monophosphate‐activated protein kinase (AMPK) activation.
Journal of cellular biochemistry  •  2019  |  View Paper
Show More